Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes

Human Gene Therapy

Volumn 7, Issue 2, 1996, Pages 223-230

  Sugaya, Susumu ^a   Fujita, Kazuyuki ^a   Kikuchi, Akira ^a   Ueda, Hiroyuki ^a   Takakuwa, Koichi ^a   Kodama, Shoji ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; LIPOSOME; LUCIFERASE; THYMIDINE KINASE; VIRUS DNA;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PLASMID; PROMOTER REGION; REPORTER GENE; SIMIAN VIRUS 40; TARGET CELL DESTRUCTION; TUMOR CELL; TUMOR REGRESSION; TUMOR VOLUME; VIRUS GENE;

DNA VIRUSES; HERPES; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; SIMPLEXVIRUS;

EID: 0030026172     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.2-223     Document Type: Article

References (32)

1. AOKI, Y., ADACHI, S., YOSHIYA, N., HONMA, N., and KANAZAWA, K. (1989). Establishment and characterization of human ovarian endometrioid carcinoma cell line. Hum. Cell (Jpn. Ed.) 2(Suppl.), 46.
2. AMATI, B., DALTON, S., BROOKS, M.W., LITTLEWOOD, T.D., EVANS, G.I., and LAND, H. (1992). Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423-426.
3. BATTEY, J., MOULDING, C., TAUB, R., MURPHY, W., STEWART, T., POTTER, H., LENOIR, G., and LEDER, P. (1983). The human c-myc oncogene: Structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34, 779-787.
4. BEHR, J.P., DEMENEIX, B., LOEFFLER, J.P., and PEREZ-MULUL J. (1989). Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA 86, 6982-6986.
5. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther 4, 725-731.
6. BISHOP, J.M. (1983). Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52, 301-310.
7. CHEN, S., CHEN, X. H.L., WANG, Y., KOSAI, K., FINEGOLD, M.F., RICH, S.S., and WOO, S.L.C. (1995). Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581.
8. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDHELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
10. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
11. GAO, X., and HUANG, L. (1991). A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285.
12. GARVER, R.I., JR., GOLDSMITH, K.T., RODU, B., HU, P., SORSCHER, E.J., and CURIEL, D.T. (1994). Strategy for achieving selective killing of carcinomas. Gene Ther. 1, 46-50.
13. GIARD, D.J., AARONSON, S.A., TODARO, G.J., ARNSTEIN, P., KERSEY, J.H., DOSIK, H., and PARKS, W.P. (1973). In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417-1421.
14. GUTIERREZ, A.A., LEMOINE, N.R., and SIKORA, K. (1992) Gene therapy for cancer. Lancet 339, 715-721.
15. HOGQUIST, K.A., NETT, M.A., UNANUE, E.R., and CHAPLIN, D.D. (1991). Interleukin 1 is processed and released during apotosis. Proc. Natl. Acad. Sci. USA 88, 8485-8489.
16. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-meditated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039-8043.
17. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., and DAVIS, S.T. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA 91, 8302-8306.
18. KIKUCHI, Y., IWANO, I., and KATO, K. (1984). Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Biochem. Biophys. Res. Commun. 123, 385-389.
19. KRETZNER, L., BLACKWOOD, E.M., and EISENMAN, R. (1992). Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426-429.
20. LEVENTIS, R., and SILVIUS, J.R. (1990). Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim. Biophys. Acta. 1023, 124-132.
21. MILLER, A.D. (1992). Human gene therapy comes age. Nature 357, 455-460.
22. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
23. NABEL, G.J., NABEL, E.G., YANG, Z., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311.
24. OSAKI, T., TANIO, Y., TACHIBANA, I., HOSOE, S., KUMAGAI, T., KAWASE, I., OIKAWA, S., and KISHIMOTO, T. (1994). Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5258-5262.
25. QUINN, A., MOORE, G.E., MORGAN, R.T., and WOODS, L.K. (1979). II Lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39, 4914-4924.
26. RAM, Z., CULVER, K.W., WALLBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
27. SORSCHER, E.J., PENG, S., BEBOK, Z., ALLAN, P.W., BENNETT, L.L., and PARKER, W.B. (1994). Tumor cell bystander killing in colonic carcinoma utilizing the Esherichia coli DeoD gene to generate toxic purines. Gene Ther. 1, 233-238.
28. TANAKA, K., ISSELBACHER, K.J., KHOURY G., and JAY, G. (1985). Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228, 26-30.
29. VILE, R.G., and HART, I.R. (1993). In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res. 53, 962-967.
30. VILE, R.G., and HART, I.R. (1993). Use of tissue-specific expression of herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860-3864.
31. WAGNER, M.J., SHARP, J.A., and SUMMERS, W.C. (1981). Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 78, 1441-1445.
32. ZHOU, X., KLIBANOV, A.L., and HUANG, L. (1991). Lipophylic polylysines mediated efficient DNA transfection in mammalian cells. Biochim. Biophys. Acta 1065, 8-14.